The modern workplace is entering a period of rapid transformation as companies adopt artificial intelligence to increase productivity while simultaneously confronting rising employee benefit costs.
Two recent developments illustrate the tension clearly: Meta’s chief technology officer has argued that employees should use productivity gains from AI to accomplish more work rather than simply take more time off.
While Starbucks is reportedly ending coverage for GLP-1 medications used for weight loss as the cost of providing the benefit increases.
The developments highlight a fundamental question about the future of employment: who ultimately benefits when technology makes workers more productive and healthcare becomes more expensive?
Register for the next Tekedia Mini-MBA.
Register for Tekedia AI in Business Masterclass.
Join Tekedia Capital Syndicate and co-invest in great global startups.
At Meta, the growing use of artificial intelligence is changing expectations around what employees can accomplish. AI tools can automate repetitive tasks, accelerate software development, assist with research and analysis, and reduce the time required to complete routine assignments.
From a management perspective, these gains create an opportunity to increase output without proportionally increasing headcount. The expectation that employees should simply use AI to do more work raises important questions about productivity and working conditions.
If an employee can complete a task in two hours instead of four because of AI, the productivity gain could theoretically be converted into additional output, shorter working hours, higher compensation, or some combination of the three.
Companies determine how much of that efficiency becomes an organizational benefit and how much is shared with workers. Meta’s position reflects the increasingly competitive environment surrounding the technology industry.
As companies spend billions of dollars on AI infrastructure, models and talent, executives are under pressure to demonstrate measurable returns.
AI therefore becomes more than a productivity tool; it becomes part of a broader strategy to increase organizational efficiency and maintain competitiveness. The healthcare side of the equation presents a different challenge.
Starbucks’ decision to end GLP-1 coverage for weight loss reportedly reflects the financial pressure associated with providing increasingly expensive medications.
GLP-1 drugs have become highly sought-after because of their effectiveness in treating obesity and, in some cases, diabetes.
Their growing popularity, however, has created significant challenges for employers and insurers attempting to control healthcare spending. For companies, employee benefits are a major component of total compensation.
Expensive treatments can increase insurance premiums and force employers to reconsider which medications and conditions should receive coverage. Removing coverage can reduce costs, but it can also make healthcare less accessible for workers who depend on employer-sponsored insurance.
The two developments reveal a broader economic pattern. Companies are asking workers to embrace technologies that increase output while simultaneously reassessing benefits that increase operating expenses.
In both cases, corporate decision-making is being shaped by the same objective: improving efficiency and controlling costs. The central debate is therefore not whether AI will make workers more productive or whether healthcare costs will continue rising.
Both trends are already influencing businesses. The more consequential question is how the gains and burdens will be distributed. If AI substantially increases productivity, employees may increasingly expect higher wages, reduced working hours, or stronger benefits in return.
Meanwhile, employers will continue looking for ways to control healthcare expenses without undermining recruitment and retention. The future workplace will ultimately be shaped by this balance.
Corporate policies, labor expectations, compensation structures and benefit decisions will determine whether the next era of work produces simply more output—or a meaningful improvement in the quality of working life.